Germany's spiralling public health deficit
This article was originally published in Clinica
Executive Summary
Germany's statutory health insurance system (GKV) has recorded a deficit of around DM 7,300 million ($4,940 million) in the first half of the year. This compares with DM 7,000 million for the whole of 1995. Krankenkassen expenditure continues to exceed income from contributions: in west Germany expenditure rose 2.9% compared with an increase in income of only 1.4%, while the corresponding figures for east Germany are 6.2% and 1.9%.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.